Latest article
ViaCyte Declares Initiation of Part 2 Research of Encapsulated Cell Remedy for Kind 1...
SAN DIEGO, February 3, 2021 / PRNewswire / - ViaCyte, Inc., a clinical-stage regenerative medicine company, announced today that the first patients with type...
Common train might stop sort 2 diabetes: Research
Washington Mar 6 (ANI): Regular exercise is known to have many health benefits, and now another benefit of regular exercise has emerged.Regular physical activity...
Youngster vitamin outcomes good for Bounce with Jill’s digital training program
PITTSBURGH - The first Jump with Jill Digital Tour took place in 48 schools in Pennsylvania and Texas from April 26 to June 10,...